Clinical Trial Update: IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous immunoglobulin (IVIG) for autoimmune small fiber neuropathy associated with antibodies TS-HDS, FGFR-3, or Plexin D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Small Fiber Neuropathy
• Immune-mediated Neuropathy
• Inflammatory Polyneuropathy
• Small Fiber Neuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Endeavor Health | Conditions: Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy | Phase 2 | Status: RECRUITING